| Literature DB >> 26504504 |
Luis Antonio Moreno-Ruíz1, David Ibarra-Quevedo1, Erika Rodríguez-Martínez2, Perla D Maldonado3, Benito Sarabia-Ortega1, José Gustavo Hernández-Martínez1, Beda Espinosa-Caleti1, Beatriz Mendoza-Pérez1, Selva Rivas-Arancibia2.
Abstract
The oxidative stress state is characterized by an increase in oxygen reactive species that overwhelms the antioxidant defense; we do not know if these pathological changes are correlated with alterations in left ventricular mechanics. The aim was correlating the oxidative stress state with the left ventricular global longitudinal strain (GLS) and the left ventricular end diastolic pressure (LVEDP). Twenty-five patients with essential hypertension and 25 controls paired by age and gender were studied. All of the participants were subjected to echocardiography and biochemical determination of oxidative stress markers. The hypertensive patients, compared with control subjects, had significantly (p < 0.05) higher levels of oxidized proteins (5.03 ± 1.05 versus 4.06 ± 0.63 nmol/mg), lower levels of extracellular superoxide dismutase (EC-SOD) activity (0.045 ± 0.02 versus 0.082 ± 0.02 U/mg), higher LVEDP (16.2 ± 4.5 versus 11.3 ± 1.6 mm Hg), and lower GLS (-12% versus -16%). Both groups had preserved ejection fraction and the results showed a positive correlation of oxidized proteins with GLS (r = 0.386, p = 0.006) and LVEDP (r = 0.389, p = 0.005); we also found a negative correlation of EC-SOD activity with GLS (r = -0.404, p = 0.004) and LVEDP (r = -0.347, p = 0.014).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26504504 PMCID: PMC4609485 DOI: 10.1155/2015/502107
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Echocardiographic determination of myocardial longitudinal deformation. Selection of regions of interest for longitudinal strain quantification in four chambers (a), three chambers (b), and two chamber (c) projections. Longitudinal strain curves of a control (d) and hypertensive (e) patient.
Anthropometric and demographic variables of both study groups.
| Variables | Group I: control | Group II: hypertension |
|---|---|---|
| Age (years) | 43.3 ± 8.04 | 43.8 ± 10.2 |
| Women | 10 (40) | 10 (40) |
| Weight (kg) | 68.9 ± 10.8 | 79.8 ± 12.4 |
| Height (m) | 1.65 ± 0.1 | 1.64 ± 0.1 |
| Corporal mass index (kg/m2) | 24.8 ± 1.0 | 29.4 ± 1.8 |
| Systolic pressure (mm Hg) | 100 (80–120)† | 130 (90–150)† |
| Diastolic pressure (mm Hg) | 60 (50–80)† | 70 (60–90)† |
| Heart rate (bpm) | 67 (56–75) | 70 (60–90) |
Values represent means ± SD, median (minimum-maximum) or n (percent). p < 0.05 (Student's t-test), † p < 0.05 (Mann-Whitney U test).
Conventional echocardiographic measurements in both study groups.
| Variables | Group I: control | Group II: hypertension |
|---|---|---|
| LA (mm) | 35 (26–40)† | 39 (33–48)† |
| RA (mm) | 37 (32–41) | 38 (35–49) |
| LVDD (mm) | 44.3 ± 4.2 | 43.9 ± 2.9 |
| LVSD (mm) | 26 ± 3.6 | 25.6 ± 2.9 |
| S (mm) | 10 (8–11)† | 13 (9–14)† |
| PW (mm) | 10 (8–11)† | 13 (9–14)† |
| RVDD (mm) | 26 (23–30)† | 28 (25–32)† |
| AoR (mm) | 30 (25–35) | 31 (27–35) |
| AoA (mm) | 20 (17–22) | 20 (17–21) |
| LVESV (mL) | 25 (13–42) | 22 (16–39) |
| LAV (mL) | 32.12 ± 12.2 | 49.3 ± 10.4 |
| RAV (mL) | 33.9 ± 11.4 | 43.6 ± 13.1 |
| PSP (mm Hg) | 25.5 ± 3.3 | 29.2 ± 5.5 |
| LVEF | 0.70 ± 0.05 | 0.70 ± 0.06 |
Values represent means ± SD, median (minimum-maximum). LA: left atrium; RA: right atrium; LVDD: left ventricle diastolic diameter; LVSD: left ventricle systolic diameter; S: interventricular septum; PW: posterior wall; RVDD: right ventricle diastolic diameter; AoR: aortic root; AoA: aortic annulus; LVESV: left ventricle end systolic volume; LAV: left atrial volume; RAV: right atrial volume; PSP: pulmonary systolic pressure; LVEF: left ventricle ejection fraction. p < 0.05 (Student's t-test), † p < 0.05 (Mann-Whitney U test).
Ventricular mechanics parameters measured by pulsed, M-color, and tissular Doppler and speckle tracking.
| Variables | Group I: control | Group II: hypertension |
|---|---|---|
| E wave, cm/s | 77 (49–118)† | 61 (44–87)† |
| A wave, cm/s | 56 (38–94)† | 92 (67–103)† |
| E/A ratio | 1.2 (1.0–2.2)† | 0.7 (0.6–0.9)† |
| DT, ms | 194 (127–246)† | 257 (194–300)† |
| IRT, ms | 77 (63–95)† | 123 (103–140)† |
| E′ wave, cm/s | 11.7 ± 1.9 | 6.3 ± 2.04 |
| A′ wave, cm/s | 8.3 ± 1.7 | 8.8 ± 1.0 |
| E/E′ ratio | 6.6 ± 1.1 | 10.2 ± 3.1 |
| LVEDP, mm Hg | 11.3 ± 1.6 | 16.2 ± 4.5 |
| PV color, cm/s2 | 69 (52–99)† | 40 (23–48)† |
| GLS, % | −16.9 (−13.1 to −22)† | −12.6 (−6.4 to −15.8)† |
Values represent means ± SD, median (minimum-maximum). DT: E wave deceleration time; IRT: isovolumetric relaxation time; LVEDP: left ventricle end diastolic pressure (by Nagueh formula); PV color: transmitral color propagation velocity; GLS: left ventricle global longitudinal strain. p < 0.05 (Student's t-test), † p < 0.05 (Mann-Whitney U test).
Figure 2Total activity of EC-SOD (a) and levels of oxidized proteins (b) in control and hypertensive group. EC-SOD: extracellular superoxide dismutase. Student's t-test.
Figure 3Relationship between global longitudinal strain and extracellular superoxide dismutase activity (a) and oxidized proteins (b). Relationship between left ventricular end diastolic pressure and total extracellular superoxide dismutase activity (c) and oxidized proteins (d). GLS: global longitudinal strain; EC-SOD: extracellular superoxide dismutase; LVEDP: left ventricular end diastolic pressure.